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Abstract 
Background 
Guidelines for management of the second stage have been proposed since the 1800s 
and were created largely by expert opinion. Current retrospective data are mixed 
regarding differences in maternal and neonatal outcomes with a prolonged second 
stage. There are no randomized controlled trials that have evaluated whether extending 
the second stage of labor beyond current American College of Obstetricians and 
Gynecologists recommendations is beneficial. 
Objective 
The purpose of this study was to evaluate whether extending the length of labor in 
nulliparous women with prolonged second stage affects the incidence of cesarean 
delivery and maternal and neonatal outcomes. 
Study Design 
We conducted a randomized controlled trial of nulliparous women with singleton 
gestations at 36 0/7 to 41 6/7 weeks gestation who reached the American College of 
Obstetricians and Gynecologists definition of prolonged second stage of labor, which is 
3 hours with epidural anesthesia or 2 hours without epidural anesthesia. Women were 
assigned randomly toextended labor for at least 1 additional hour, or to usual labor, 
which was defined as expedited delivery via cesarean or operative vaginal delivery. The 
exclusion criteria were intrauterine fetal death, planned cesarean delivery, age <18 
years, and suspected major fetal anomaly. Primary outcome was incidence of cesarean 
delivery. Maternal and neonatal outcomes were compared secondarily. Statistical 
analysis was done by intention-to-treat. 
Results 
Seventy-eight nulliparous women were assigned randomly. All of the women had 
epidural anesthesia. Maternal demographics were not significantly different. The 
incidence of cesarean delivery was 19.5% (n = 8/41 deliveries) in the extended labor 
group and 43.2% (n = 16/37 deliveries) in the usual labor group (relative risk, 0.45; 95% 
confidence interval, 0.22–0.93). The number needed-to-treat to prevent 1 cesarean 
delivery was 4.2. There were no statistically significant differences in maternal or 
neonatal morbidity outcomes. 
Conclusion 
Extending the length of labor in nulliparous women with singleton gestations, epidural 
anesthesia, and prolonged second stage decreased the incidence of cesarean delivery 
by slightly more than one-half, compared with usual guidelines. Maternal or neonatal 
morbidity were not statistically different between the groups; however, our study was 
underpowered to detect small, but potentially clinical important, differences. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Introduction 
 
Guidelines for the management of the second stage of labor have been proposed since 
the 1800s and were created largely by expert opinion. The first large retrospective data 
collection was done by Hellman and Prystowsky1 in 1952, which showed that women 
who had a second stage of labor within 2 hours had a decreased rate of postpartum 
hemorrhage, fever, and neonatal death. Friedman,3 in 1955, evaluated the natural 
course of labor and noted that most nulliparous women without epidural anesthesia 
delivered within 2 hours.2Recent data have suggested that obstetricians may want to 
extend the time limit to 3 hours to achieve a vaginal delivery for nulliparous women 
without an epidural and to 4 hours in those with an epidural. However, current 
retrospective data are mixed regarding differences in maternal and neonatal outcomes 
with a prolonged second stage.4, 5, 6 and 7 There are no randomized controlled trials that 
have evaluated whether extending the second stage of labor beyond current American 
College of Obstetricians and Gynecologists (ACOG) recommendations is beneficial.8 
The aim of this study was to evaluate whether extending the time limit of second stage 
of labor beyond current ACOG guidelines would affect the incidence of cesarean 
delivery (CD). Maternal and perinatal outcomes were also assessed. 
Materials and Methods 
This study was conducted from March 2014 until July 2015 at Thomas Jefferson 
University Hospital. The protocol was approved by the institutional review board, and all 
women provided written informed consent before assignment. Eligible nulliparous 
women were at least 18 years old with singleton pregnancies of at least 36 weeks 
gestation, cephalic presentation, and category I or II fetal heart tracings. Exclusion 
criteria included category III fetal heart tracing, previous vaginal delivery at ≥24 weeks 
gestation, multiple pregnancy, intrauterine fetal death, trial of labor after CD, planned 
CD, or suspected major fetal anomaly. Women were consented well before the second 
stage started, either in the office during prenatal care or early on admission to labor and 
delivery. Participating women did not receive compensation. 
This study was a randomized controlled trial. Randomization was completed by a 
computer-generated list that used random block sizes of 8, 10, and 12. Group 
assignments were made based on sequentially numbered opaque sealed envelopes. 
The sequence was generated by the primary investigator (A.C.G.). Participants were 
consented by labor and delivery providers in the office or on admission. Women were 
assigned randomly to either “extended care” or “usual care” groups. Randomization was 
stratified by epidural status. Suggested treatment for women who were assigned 
randomly to the extended care group was continuing the second stage for at least 1 
additional hour after reaching the ACOG prolonged second stage criteria (ie, after 3 
hours in the second stage of labor with an epidural or 2 hours without an epidural). 
Suggested treatment for women who were assigned randomly to the usual care group 
was delivery soon after reaching the criteria for prolonged second stage listed by 
ACOG. Women were assigned randomly by labor and delivery staff at either the 3-hour 
mark (with epidural) or 2-hour mark (without epidural). 
Except for the suggested management regarding length of the second stage as per 
randomization, the second stage of labor was managed according to the individual 
provider on labor and delivery. All patients were treated by house staff under the 
supervision of an attending physician. In general, on the finding of complete dilation, 
women without an urge to push were offered delayed pushing (ie, waiting about 1 hour 
before starting to push). Once pushing started, this usually was done via Valsalva 
maneuver. Delayed pushing was included in the total time of second stage. After 
reaching ACOG criteria for prolonged second stage, women in the extended care group 
were given at least 1 additional hour to have a spontaneous vaginal delivery (SVD) then 
delivered by the labor and delivery team with the option of CD, forceps-assisted vaginal 
delivery (FAVD), or vacuum-assisted vaginal delivery (VAVD). Women in the usual care 
group who reached ACOG criteria for prolonged second stage were at that point 
expeditiously delivered by the labor and delivery team with the option of CD, FAVD, or 
VAVD. 
Primary outcome was CD. Maternal secondary outcome measures included incidence 
of: vaginal delivery (SVD and operative vaginal delivery [OVD] combined), SVD, OVD, 
chorioamnionitis, endometritis, postpartum hemorrhage (defined as >500 mL estimated 
blood loss in a vaginal delivery and >1000 mL estimated blood loss in a CD), 
transfusion, third- and fourth-degree laceration, and cervical laceration. 
Neonatal secondary outcome measures included shoulder dystocia, birthweight, 
neonatal intensive care unit (NICU) admission, ventilation support with the use of 
continuous positive airway pressure or greater, sepsis, seizure, umbilical artery cord 
pH <7.10, perinatal death, and NICU length of stay. 
Race/ethnicity was classified by the study participants. The classifications were non-
Hispanic white, non-Hispanic black, Asian, Hispanic, or other. 
A priori sample size estimation was calculated with an α of .05 and β of .20. Based on 
observations of successful vaginal delivery at 4-hour second stage by Mentigoglu 
et al,9 and on more recent delivery rates at our institution, we estimated that the CD rate 
in the usual care group (ie, soon after 3 hours with an epidural or 2 hours without an 
epidural) would be 50%, with a reduction to 20% at 4 hours with an epidural or 3 hours 
without an epidural. A total sample of 78 women was estimated to provide 80% power 
to detect a >2-fold decrease in CD rate. A subgroup analysis was planned for women 
with an epidural vs women without an epidural. Potential confounders were planned to 
be analyzed to determine confounding vs interaction. 
The data analysis for this study was generated with SPSS software (version 20; IBM, 
Armonk, NY). Statistical analysis was performed by the intention-to-treat principle. 
Categorical variables were compared with the use of χ2 test or Fisher exact test. 
Continuous variables were compared with the use of 2-tailed Student t test or Wilcoxon 
Rank-Sum test. A probability value of <.05 was considered statistically significant. Data 
were analyzed by the primary investigator (A.C.G.) with assistance from the Thomas 
Jefferson University Biostatistics Department. 
The Consolidated Standards of Reporting Trials guidelines were followed.10 This trial 
was registered on clinicaltrials.gov (NCT02101515). This study was not funded. 
Results 
From March 2013 through July 2015, we enrolled 78 nulliparous women, of whom 41 
women were assigned to receive extended labor and 37 women were assigned to usual 
labor. No women were excluded or lost to follow up. All had epidural anesthesia. All 
women initially received the allocated intervention; however, there was a 14.1% 
crossover rate (extended labor, 2; usual labor, 9). Reasons for crossover in the 
extended labor group were maternal request (n = 1) and nonreassuring fetal heart 
tracing (n = 1). Reasons for crossover in the usual labor group included maternal 
request (n = 4) and delivery provider decision (n = 5). No women withdrew from the 
study. There was no loss to follow up. Figure 1 shows the trial flow diagram. 
Figure options 
Overall, the women were 44.9% white and 25.6% African American. The average body 
mass index was 30.9 kg/m2; 100% of the women had an epidural, and 48.7% of the 
women had labor induced. Maternal demographics were not significantly different, 
except for insurance type (P = .03) and occiput posterior presentation (P = .03; Table 1). 
 
There was 1 failed OVD in the extended labor group and 4 failed OVDs in the usual 
labor group (P = .3). All failed OVDs were VAVDs. 
Maternal outcome measures including chorioamnionitis, endometritis, postpartum 
hemorrhage, transfusion, third-- or 4th-degree perineal lacerations, and cervical 
lacerations, did not differ between groups (Table 2). There were no differences in 
neonatal morbidity outcomes between groups (Table 3). 
 
The average time after randomization was 92 ± 65 minutes in the extended labor group 
and 78 ± 46 minutes in the usual labor group (P = 0.3). 
Subgroup analysis was performed for fetal position. In the extended labor group, 
women with fetuses in the occiput posterior position had a similar risk of CD compared 
to the usual labor group (RR 1.60; 95% CI 0.92–2.81). In comparison, in the extended 
labor group, women with fetuses in the occiput anterior position had significantly 
decreased risk of CD compared to the usual labor group (RR 0.17; 95% CI 0.04–0.75). 
Additionally, women in the extended labor group who underwent an induction of labor 
had no difference in risk of CD (RR 0.84; 95% CI 0.32–2.05) compared to the usual 
labor group. However, women in the extended labor group who presented in 
spontaneous labor had a significantly decreased risk of CD (RR 0.11; 95% CI 0.01–
0.78) compared to the usual labor group. 
Comment 
In this trial of nulliparous women with epidural anesthesia and prolonged (≥3 hours) 
second stage of labor, extending the second stage of labor decreases the incidence of 
CD by a significant percentage (55%) compared with usual labor guidelines, from 43.2% 
with usual labor to 19.5% with extended labor. Importantly, the decrease in CD was 
obtained without increasing maternal or neonatal morbidity. The number needed-to-treat 
to prevent 1 CD in this cohort of women was 4.2. 
There are several strengths of this study. First, the trial was designed as a randomized 
controlled trial with an intention-to-treat analysis, and recruitment of the desired women 
was completed. Second, there are no similar trials in the literature on this subject. Third, 
there was no loss to follow up. Fourth, there were no changes to the protocol during the 
trial. Fifth, the estimated incidence of CD of the extended labor group that we used for 
our power calculations was very similar as in the population that was studied. Last, 
recruitment was relatively easy for this study; consents were obtained from 87.3% of the 
women who were approached, which suggests that most women are highly motivated 
to have an SVD. 
Although we reached our pretrial goal for sample size, a potential limitation of this study 
was the relatively small number of women who were included. Although no maternal 
morbidity differences were found, postpartum hemorrhage, endometritis, and third- and 
fourth-degree lacerations all had wide confidence intervals. This study was 
underpowered to determine differences in these outcomes. Additionally, the time 
difference between the 2 groups was not statistically significantly different 92 ± 65 
minutes vs 78 ± 46 minutes; P = .3). The lack of time difference was contributed 
by several factors that included the 14.1% overall crossover, time spent waiting for 
operating rooms to be available, and time waiting to set up for an OVD. Nevertheless, 
the lack of time difference and the presence of crossover strengthen our results 
because of the analysis as intention-to-treat. It was the intention of extending the 
second stage of labor to at least 4 hours that seemed to have contributed to the results. 
The generalizability of this study was limited by the fact that no women without an 
epidural were assigned randomly. Out of the entire cohort of nulliparous women who 
presented to labor and delivery during the study time period and did not have an 
epidural, only 4 of 107 women (3.7%) had prolonged second stage >2 hours. Of these 4 
women, none was consented for the trial. This is an important finding because it 
supports previous studies that suggest that epidural anesthesia is a significant 
contributor to a prolonged second stage.11 and 12 
There were differences in insurance type and fetal position between groups. We 
analyzed both of these possible confounders and found that they had no interaction with 
the results. The effects were in different directions for each insurance type and fetal 
position. Thus, there does not appear to be confounding, but this is more likely effect 
modification. The safety and effectiveness of prolonged second stage has been 
evaluated previously only in retrospective studies. There are only 2 studies that 
specifically report outcomes for nulliparous women with epidural anesthesia.7 and 9 In 1 
retrospective review that included 548 nulliparous women with prolonged second stage 
and an epidural who were allowed to labor longer, the CD rate (17.9%) was comparable 
with our extended labor results (19.5%). A second larger retrospective study of 
3533 nulliparous women with prolonged second stage plus epidural who were allowed 
to labor longer also confirmed a similar CD rate of 20.0%. In terms of maternal and 
neonatal morbidities, this study showed rates of third- and fourth-degree laceration of 
8.8%, postpartum hemorrhage of 7.3%, chorioamnionitis of 11.1%, endometritis of 
1.2%, and a NICU admission rate of 7.1%. Importantly, our maternal and neonatal 
complication incidences did not differ by group. However, our incidences of 
chorioamnionitis and NICU admission in general were higher across both the extended 
labor and usual labor groups than those found by prior studies, although the findings 
were similar for the other outcomes. These findings could be explained by differences in 
our study populations, but possibly they also reflect underreporting in retrospective data 
vs our prospective data. Other retrospective studies of prolonged second stage are 
difficult to compare with our data because the results are not stratified by epidural 
status. 
Extending the length of labor in nulliparous women with singleton gestations, epidural 
anesthesia, and a prolonged second stage decreased the incidence of CD by slightly 
more than one-half, compared with usual labor. Maternal or neonatal morbidity were not 
statistically different between the groups, but our study was underpowered to detect 
small but potentially clinical important differences. A larger trial would be necessary to 
address further the safety of the extended protocol. 
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 Figure 1.  
Consolidated Standards of Reporting Trials flow diagram 
Flow diagram of study participants. 
NFRHT, nonreassuring fetal heart tracing. 
Gimovsky & Berghella. Randomized controlled trial of prolonged second stage. Am J Obstet 
Gynecol 2016. 
 Figure 2.  
Delivery outcomes 
Type of delivery by group. 
CD, cesarean delivery; CI, confidence interval; OVD, operative vaginal delivery; RR, relative 
risk; SVD, spontaneous vaginal delivery. 
Gimovsky & Berghella. Randomized controlled trial of prolonged second stage. Am J Obstet 
Gynecol 2016. 
  
 
 
 
 
 
 
 
 
 
 
 
Table 1. 
Maternal, obstetric, and neonatal characteristics 
Characteristics 
Extended labor (n = 
41) 
Usual labor (n = 
37) 
Maternal age, ya 27.6 ± 4.7 28.7 ± 5.4 
Epidural anesthesia, n (%) 41 (100) 37 (100) 
Ethnicity (non-Hispanic), n (%) 37 (90.2) 36 (97.3) 
Race, n (%)   
 Non-Hispanic white 18 (43.9) 17 (45.9) 
 Non-Hispanic black 11 (26.8) 9 (24.3) 
 Asian 11 (26.8) 11 (29.7) 
 Other 1 (2.4) 0 
Insurance type, n (%)b   
 Private 21 (51.2) 28 (75.7) 
 Public or self pay 20 (48.8) 9 (24.3) 
Pregnancy complications, n (%)   
 Gestational diabetes mellitus 4 (9.8) 3 (8.1) 
 Pregestational diabetes mellitus 0 1 (2.7) 
Hypertensive disorder, n (%)   
 Chronic hypertension 0 2 (5.4) 
 Gestational hypertension 6 (14.6) 2 (5.4) 
 Preeclampsia 3 (7.3) 3 (8.1) 
Body mass index at delivery, kg/m2a 32.1 ± 6.2 29.5 ± 4.8 
Prenatal weight gain, kga 15.2 ± 5.6 14.1 ± 6.2 
Gestational age at delivery, wka 40.4 ± 0.9 40.0 ± 1.3 
Induction of labor, n (%) 22 (53.7) 16 (43.2) 
Cervical ripening, n (%) 11 (26.8) 8 (21.6) 
Dilation on admission, cma 3.0 ± 1.8 3.8 ± 1.7 
Oxytocin use, n (%) 34 (82.9) 30 (81.1) 
Artificial rupture of membranes, n (%) 28 (68.3) 17 (45.9) 
Contraction frequency in 2nd stage, mina 2.9 ± 1.0 3.3 ± 1.4 
Supine position in 2nd stage, n (%) 38 (92.7) 36 (97.3) 
Delayed pushing, n (%) 34 (82.9) 30 (81.1) 
Patient willing to do operative vaginal delivery, n 
(%) 
36 (87.8) 27 (73.0) 
Fetal position, n (%)c   
 Occiput anteriord 34 (82.9) 20 (54.1) 
 Occiput posteriore 7 (17.1) 15 (40.5) 
 Occiput transverse 0 2 (5.4) 
Male fetus, n (%) 28 (68.3) 19 (51.4) 
Gimovsky & Berghella. Randomized controlled trial of prolonged second stage. Am J Obstet 
Gynecol 2016. 
a. Data are given as mean ± standard deviation 
b P = .03 
c Across all 3 fetal positions, P = .015 
d P = .01 
e P = .03. 
 
Incidence of CD was 19.5% in the extended labor group and 43.2% in the usual labor 
group (relative risk [RR], 0.45; 95% confidence interval [CI], 0.22–
0.93; Table 2, Figure 2). The number needed to treat to prevent 1 CD was 4.2. SVD 
was significantly increased in the extended labor group (RR, 2.71; 95% confidence 
interval [CI], 1.30–5.62); OVD was not significantly different between groups (RR, 0.77; 
95% CI, 0.41–1.45). When we analyzed FAVD (n = 5 in extended labor group and n = 3 
in usual labor group) and VAVD (n = 7 in extended labor group and n = 11 in usual labor 
group) separately, there was also no difference between groups (FAVD: RR, 1.50; 95% 
CI, 0.39–5.86; VAVD: RR, 0.57; 95% CL, 0.25–1.32). Results were similar when 
adjusted for confounders. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2. 
Maternal outcomes 
Outcome 
Extended labor 
(n = 41), n (%) 
Usual labor 
(n = 37), n 
(%) 
Relative 
risk 
95% Confidence 
interval 
Cesarean delivery 8 (19.5) 16 (43.2) 0.45 0.22–0.93a 
Vaginal delivery 33 (80.5) 21 (56.8) 1.42 1.03–1.95a 
Spontaneous vaginal 
delivery 
21 (51.2) 7 (18.9) 2.71 1.30–5.62a 
Operative vaginal delivery 12 (29.3) 14 (37.8) 0.77 0.41–1.45a 
Chorioamnionitis 11 (26.8) 13 (35.1) 0.76 0.39–1.49a 
Endometritis 1 (2.4) 1 (2.7) 0.90 0.06–13.92b 
Postpartum hemorrhage 8 (19.5) 3 (8.1) 2.41 0.67–8.40b 
Transfusion 1 (2.4) 0 Not 
estimable 
Not estimable 
Third-/fourth-degree 
perineal laceration 
6 (14.6) 1 (2.7) 5.41 0.68–42.90b 
Cervical laceration 0 0 — — 
Gimovsky & Berghella. Randomized controlled trial of prolonged second stage. Am J Obstet 
Gynecol 2016. 
a. Chi-square test 
b.  Fisher’s exact test. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3. 
Neonatal outcomes 
Outcome 
Extended 
labor (n = 41) 
Usual 
labor ( n = 
37) 
Relative 
risk 
95% 
Confidence 
interval Pvalue 
Shoulder dystocia, n (%) 1 (2.4) 0 (0) Not 
estimable 
Not estimable — 
Birthweight, ga 3437 ± 527 3506 ± 
534 
— — .6b 
Neonatal intensive care 
unit admission, n (%) 
13 (31.7) 14 (37.8) 0.8 (0.46–1.54)  
Continuous positive 
airway pressure or 
greater, n (%) 
1 (2.4) 3 (8.1) 0.3 (0.03–2.77)  
Sepsis, n (%) 0 0 — — — 
Seizure, n (%) 0 0 — — — 
Umbilical artery cord pH 
<7.10, n (%) 
0 0 — — — 
Perinatal death, n (%) 0 0 — — — 
Neonatal intensive care 
unit length of stay, da 
2.66 ± 1.02 4.03 ± 
5.67 
— — .3c 
Gimovsky & Berghella. Randomized controlled trial of prolonged second stage. Am J Obstet 
Gynecol 2016. 
a Data are given as mean ± standard deviation 
b Two sample t-test 
c Wilcox Rank-Sum test. 
